-
Dual-antiplatelet therapy with aspirin and clopidogrel is recommended for patients with known vascular disease or multiple risk factors for vascular disease. However, little is known about the long-term bleeding risk of such therapy.
-
-
Access-site bleeding is one of the major complications of percutaneous coronary intervention (PCI). It is associated with the need for blood transfusions, increased length of stay, and increased healthcare expenditure.
-
The can rapid-risk stratification of unstable angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) is a registry study of acute coronary-syndrome patients.
-
Many patients who receive pacemakers or implantable cardioverter defibrillators (ICDs) are chronically treated with antiplatelet agents, warfarin, or a combination of the two. In this paper, Tompkins and colleagues from the Johns Hopkins Hospital report the results of a retrospective review of antiplatelet and anticoagulant management in patients receiving cardiac-rhythm devices.
-
The evolution of percutaneous coronary intervention (PCI) techniques has resulted in PCI becoming a reasonable alternative to coronary artery bypass graft (CABG) surgery in selected patients with unprotected left-main coronary artery (ULMCA) stenosis.
-
The Medtronic Sprint-Fidelis ICD-lead family is associated with an increased risk for lead fracture.
-
Postural orthostatic tachycardia syndrome (POTS) is a disabling orthostatic intolerance that mainly occurs in pre-menopausal women.
-
Aggressive approach to CVD reduces MI, folic acid and vitamin B12 for CAD, corticosteroids for acute exacerbations of COPD, prescription drug abuse among young adults, and ARBs and cancer risk.
-
In addition to metformin, dietary therapy is the cornerstone of conventional treatment recommendations for polycystic ovary syndrome (PCOS) to prevent the development of related comorbidities such as type 2 diabetes, heart disease, menstrual irregularities, and infertility.
